Citation:Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM 2012

From Cancer Guidelines Wiki

Citation


Hyde MA, Hadley ML, Tristani-Firouzi P, Goldgar D, Bowen GM. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Arch Dermatol 2012 May;148(5):592-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22431716.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What are the most effective treatment/management interventions to improve outcomes in patients with lentigo maligna?Tamsin Parrishcompleted
What are the most effective treatment/management interventions to improve outcomes in patients with lentigo maligna?Meghna Kakanicompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Effective interventions to improve outcomes in lentigo maligna?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Effective interventions to improve outcomes in lentigo maligna?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Effective interventions to improve outcomes in lentigo maligna?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Effective interventions to improve outcomes in lentigo maligna?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What are the most effective treatment/management interventions to improve outcomes in patients with lentigo maligna?